Analysed TIZIANA LIFE SCIENCES LTD (TLSA:NASDAQ) News Sources
Tiziana Announces Data Showing Nasal Anti-CD3 Improves Cognition Associated with Aging
01-04-2026
yahoo.com
Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates CSF Inflammation, Upregulates Neuroprotective Pathways, and Correlates with Reduced Microglial Activation on PET Scans in na-SPMS Patients with PIRA
25-02-2026
yahoo.com
While insiders own 43% of Tiziana Life Sciences Ltd (NASDAQ:TLSA), individual investors are its largest shareholders with 53% ownership
09-02-2026
yahoo.com
Tiziana Life Sciences Announces the Peer-Reviewed Publication of Clinical Study Results for Intranasal Foralumab
20-01-2026
yahoo.com
Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares
16-01-2026
yahoo.com
Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $17.6 Million
16-01-2026
yahoo.com
Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco
09-01-2026
yahoo.com
What is the current price of TIZIANA LIFE SCIENCES LTD (TLSA:NASDAQ)?
The current price of TIZIANA LIFE SCIENCES LTD (TLSA:NASDAQ) is $1.18.
TIZIANA LIFE SCIENCES LTD (TLSA:NASDAQ) absolute price change since previous trading day?
The absolute price change of TIZIANA LIFE SCIENCES LTD (TLSA:NASDAQ) since the previous trading day is $-0.08.
TIZIANA LIFE SCIENCES LTD (TLSA:NASDAQ) percentage price change since previous trading day?
The percentage price change of TIZIANA LIFE SCIENCES LTD (TLSA:NASDAQ) since the previous trading day is -6.3492%.
What is the most recent average sentiment score for TIZIANA LIFE SCIENCES LTD (TLSA:NASDAQ)?
The most recent average sentiment score for TIZIANA LIFE SCIENCES LTD (TLSA:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for TIZIANA LIFE SCIENCES LTD (TLSA:NASDAQ)?
The most recent sentiment for TIZIANA LIFE SCIENCES LTD (TLSA:NASDAQ) is .
SEC-8K** Filing Available For TIZIANA LIFE SCIENCES LTD (TLSA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.